Subscribe to our monthly newsletter to receive exclusive news updates and medical AI insights.
News
Featured News
Beijing Anzhen Hospital Successfully Implements DeepVessel FFR
On August 24, Keya Medical’s flagship product, DeepVessel FFR, was successfully implemented in Beijing Anzhen Hospital.
Deep Learning-based CT-FFR Reduces the Need for Invasive Coronary Angiography
A new study conducted by researchers at the First Affiliated Hospital of Jinan University demonstrates that deep learning-based CT-FFR (DL-CTFFR) can reduce the need for invasive coronary angiography (ICA) and improve outcomes in patients with stable coronary artery disease (CAD).
Coronary CTA Guidelines, Evidence, & Recommendations
Evidence is building in support of a coronary CTA-first strategy for evaluating patients with stable coronary artery disease. Learn more about the current evidence, guidelines, and recommendations.
Keya Medical Receives the 2020 Most Growth Enterprise Award from iiMedia Research
Keya Medical, a leading developer of medical AI technology, has received the Most Growth Enterprise Award granted by iiMedia Research, a third-party data mining and analysis company headquartered in China.
Dr. Kunlin Cao Named to 2021 Forbes China Up-and-Coming Businesswomen List
Keya Medical’s President of R&D, Dr. Kunlin Cao, has been recognized on the 2021 Forbes China Up-and-Coming Businesswomen list. The list highlights 20 accomplished women who have each played a significant role in shaping China’s business landscape.
The Value of Deep Learning-based CT-FFR in Detecting Coronary Stenosis & Predicting Outcomes
Researchers at Fuwai Hospital conducted a retrospective study to evaluate the performance of Keya Medical’s deep learning-based CT-FFR product in detecting hemodynamic changes in stenosis.
Cardiovascular Disease in Women: Turning the Spotlight on Women’s Hearts
Cardiovascular disease (CVD) remains the leading cause of death for women in the U.S. In honor of American Heart Month, we are highlighting the differences in women’s risk factors and primary prevention to help manage CVD in women.
Will New Value-based Care Regulations Spark Innovation?
On Jan. 19, two regulatory changes went into effect that intend to modernize the Physician Self-Referral Statute & the Anti-Kickback Statute, facilitating the shift to value-based care.
Keya Medical Raises $46M in Series D Round
Keya Medical has raised $46 million in Series D funding. This funding round was led by new and existing investors, including CICC Capital, Shanghai Artificial Intelligence Investment Fund, Qianhai Gaozu Asset Management Fund, and IN CAPITAL.
EACVI Best of Imaging: Advances in Cardiac CT
EACVI Best of Imaging introduced the latest advances in cardiac CT, promoting a patient-centric, multi-modality approach to cardiovascular disease diagnosis.
Keya Medical is Named One of the Top 50 Global Healthcare Technology Companies at World Innovators Meet 2020
Keya Medical, a leading medical AI technology company, was recognized as one of the top 50 Global Healthcare Technology Companies at the 2020 World Innovators Meet (WIM) conference held By Equal Ocean in Beijing from December 9-11.
Keya Medical Closes $30 Million Series C Funding Round Led by IDG Capital
Keya Medical announced that it has completed a $30 Million Series C Funding Round led by IDG Capital, with participation from investors Alwin Capital, Source Code Capital, and Tasly Group.
Virtual Medical AI Events in November
We have compiled a list of free virtual events hosted by professional organizations that will take place in November, covering topics in cardiology, radiology, and AI.
Products
DeepVessel FFR
CuraRad-ICH
Solutions
All Solutions
Diagnostic Solutions
Treatment Solutions
Solution Suites
